Cassava Sciences | GJELD



Debt Endring Dato
Abbott USD 14.98B 225M 2024-09
Amgen USD 60.1B 299M 2024-12
Biogen USD 6.3B 1.9M 2024-12
Cassava Sciences USD 0 0 2024-12
Eisai JPY 219.1B 36.2B 2024-12
Eli Lilly USD 33.64B 2.52B 2024-12
Geron USD 118.48M 34.64M 2024-12
J&J USD 36.63B 883M 2024-12
Merck USD 37.11B 1.02B 2024-12
Novartis USD 31.26B 828M 2024-12
Pfizer USD 64.35B 3.35B 2024-12
Roche Holding CHF 34.44B 5.23B 2024-06



Cassava Sciences GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.